ABOUT THE SUMMIT

In its third year, the North American Biocompatibility Summit (NABS) is a limited-seating event that provides industry insights and expertise sharing on the biocompatibility of medical devices. This year, session will include the latest regulatory updates, biological evaluation strategies and best practices that lead to successful biocompatibility programs in September 2021. 

Led by the medical device industry’s foremost biological safety experts, speakers will address:

  • Regulatory strategies and how they relate to ISO 10993
  • New and innovative biocompatibility methods and technologies
  • The relationship between material/chemical characterization and biocompatibility testing
  • Toxicology and risk management
  • Industry case studies

Join us for this one day exclusive summit to learn and network with top scientists, toxicologists, and industry leaders in the medical device biocompatibility field! 

COVID-19 Safety Precautions
The safety and wellness of our Clients, staff and speakers are of the highest priority and our commitment to you is to facilitate a safe, comfortable learning environment for our upcoming event. With the rise of COVID-19 cases in Hennepin County (Minneapolis area), we have elected to take the following safety measures out of an abundance of caution and care for all attendees.  

  • Masks will be required for all attendees; masks will also be worn by all venue staff.
    • Masks will not be required during breakfast, lunch or when eating during breaks.
    • Speakers, when presenting, will not be required to wear masks.
  • Attendees will be seated at tables with a social distance of three (3) feet.
  • Continental breakfast, lunch buffet and snacks will be served by venue staff only.

Should you have any additional questions, please contact Shauna Brick, Global Marketing Event Manager at sbrick@namsa.com or (763) 213-7571.

Past Summit Topics

Toxicological Risk Assessment Tools

EU MDR & GSPR Requirements & Biocompatibility Evaluation for Medical Devices

Sampling & Analysis of Volatile Organic Compounds Released from Respiratory Medical Devices

Case Study: Analysis of the Extractables/ Leachables Profile from a Ventilator Circuit in Support of a 510(k)

In Vitro Blood Loop Hemocompatibility Testing

Updates on ISO 10993-10 & Future Considerations

AdvaMed & FDA Interactions on Chemical Characterization

New Directions for the Biological Safety Evaluation of Medical Devices

Summit Schedule

7:00 – 8:00 AM

Number of Sessions Breakfast & Registration
Length of Sessions 1 hr
LEARN MORE  

8:00 – 10:00 AM

Number of Sessions 3 Topics
Length of Sessions 2 hrs
LEARN MORE  

10:00 – 10:30 AM

Networking Networking Break
Length of Sessions 30 mins
LEARN MORE  

10:30 AM – 12:00 PM

Number of Sessions 2 Topics
Length of Sessions 1 hr 30 mins
LEARN MORE  

12:00 – 12:45 PM

  
Lunch and Networking
LEARN MORE  

12:45 – 2:45 PM

Number of Sessions 3 Topics
Length of Sessions 1 hr 45 mins
LEARN MORE  

2:45- 3:15 PM

Networking Networking Break
Length of Sessions 15 mins
LEARN MORE  

3:15 – 5:00 PM

Number of Sessions 3 Topics
Length of Sessions 2 hrs 15 mins
LEARN MORE  

5:00 – 6:00 PM

Networking Networking
Length of Sessions 1 hr
LEARN MORE  

If you are interested in Sponsorship Opportunities, please contact Shauna Brick at sbrick@namsa.com or 763-213-7571.

About the Venue

EVENT LOCATION

Quincy Hall 
1325 Quincy St. NE
Minneapolis, Minn. 55413
Tel: 612-400-1754 

HOTEL INFORMATION

Delta Hotel by Marriott
1330 Industrial Blvd NE
Minneapolis, Minn. 55413
Phone: (612) 331-1900

NAMSA room block and special rates of $149-$159 held until August 31, 2021.   

As a global leader in medical device innovation, Minneapolis is a perfect location for this summit addressing one of the hottest topics in the medical device industry today. 

Due to limited seating, the number of attendees will ensure you will have the opportunity to personally connect and network with fellow attendees, speakers, and event sponsors. 

REGISTER TODAY!

Questions About The Event?

Feel free to contact us should you have any questions about the
North American Biocompatibility Summit.